Amplitude Vascular Systems dba AVS Pulse has filed a notice of an exempt offering of securities to raise $36 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Amplitude Vascular Systems dba AVS Pulse is raising up to $36,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Amplitude Vascular Systems dba AVS Pulse
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device.
To learn more about Amplitude Vascular Systems dba AVS Pulse, visit http://www.avspulse.com/
Amplitude Vascular Systems dba AVS Pulse Linkedin Page: https://www.linkedin.com/company/avspulse/
Contact:
Mark Toland, Chief Executive Officer
631-662-7393
https://www.linkedin.com/in/mark-toland-76970780/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.